Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes

@article{Rosen2004UseOA,
  title={Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes},
  author={MPH ScD Dr. Allison B. Rosen and Andrew J. Karter and Jennifer Y. Liu MPH and MPH Joe V. Selby and MSc Eric C. Schneider},
  journal={Journal of General Internal Medicine},
  year={2004},
  volume={19},
  pages={669-675}
}
BACKGROUND: Diabetes causes 45% of incident end-stage renal disease (ESRD). Risk of progression is higher in those with clinical risk factors (albuminuria and hypertension), and in ethnic minorities (including blacks, Asians, and Latinos). Angiotensin-converting enzyme inhibitors (ACE) and angiotensin receptor blockers (ARB) slow the progression of diabetic nephropathy, yet little is known about their use among patients at high risk for progression to ESRD. OBJECTIVES: To examine the prevalence… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Diabetic kidney disease in elderly individuals.

The Medical clinics of North America • 2013

References

Publications referenced by this paper.
Showing 1-10 of 63 references

Similar Papers

Loading similar papers…